These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32755038)

  • 1. Teratogen update: Amphetamines.
    Garey JD; Lusskin SI; Scialli AR
    Birth Defects Res; 2020 Sep; 112(15):1171-1182. PubMed ID: 32755038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
    National Toxicology Program
    NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Gestational Outcomes Associated With Attention-Deficit/Hyperactivity Disorder Medication Exposure During Pregnancy.
    Andrade C
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abuse of amphetamines and structural abnormalities in the brain.
    Berman S; O'Neill J; Fears S; Bartzokis G; London ED
    Ann N Y Acad Sci; 2008 Oct; 1141():195-220. PubMed ID: 18991959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential adverse effects of amphetamine treatment on brain and behavior: a review.
    Berman SM; Kuczenski R; McCracken JT; London ED
    Mol Psychiatry; 2009 Feb; 14(2):123-42. PubMed ID: 18698321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current pharmacotherapy of attention deficit hyperactivity disorder.
    Reddy DS
    Drugs Today (Barc); 2013 Oct; 49(10):647-65. PubMed ID: 24191257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sources of variation in the design of preclinical studies assessing the effects of amphetamine-type stimulants in pregnancy and lactation.
    McDonnell-Dowling K; Kelly JP
    Behav Brain Res; 2015 Feb; 279():87-99. PubMed ID: 25449844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine use for attention deficit hyperactive disorder during breastfeeding and children's neurodevelopmental outcomes: A pilot study.
    Benassayag Kaduri N; Hazan A; De-Haan T; Kohn E; Berkovitch M; Berlin M
    Psychiatry Res; 2024 Sep; 339():116047. PubMed ID: 38908263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
    Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
    Castells X; Blanco-Silvente L; Cunill R
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults.
    Castells X; Ramos-Quiroga JA; Bosch R; Nogueira M; Casas M
    Cochrane Database Syst Rev; 2011 Jun; (6):CD007813. PubMed ID: 21678370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurotoxicity of amphetamines during the adolescent period.
    Teixeira-Gomes A; Costa VM; Feio-Azevedo R; Bastos Mde L; Carvalho F; Capela JP
    Int J Dev Neurosci; 2015 Apr; 41():44-62. PubMed ID: 25482046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamines abuse and depression: Focus on TRPC channels.
    Fu YP; Wang Y
    Exp Neurol; 2023 Jun; 364():114391. PubMed ID: 36996966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation.
    Ornoy A
    Pharm Res; 2018 Feb; 35(3):46. PubMed ID: 29411149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release).
    Faraone SV
    Expert Opin Pharmacother; 2007 Sep; 8(13):2127-34. PubMed ID: 17714065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
    Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
    JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.
    Cadet JL; Krasnova IN; Jayanthi S; Lyles J
    Neurotox Res; 2007 Apr; 11(3-4):183-202. PubMed ID: 17449459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.
    Eiland LS; Bell EA; Erramouspe J
    Ann Pharmacother; 2014 Oct; 48(10):1350-5. PubMed ID: 24982313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.